These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4405717)

  • 1. In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
    Allen LM; Creaven PJ
    Cancer Chemother Rep; 1972 Oct; 56(5):603-10. PubMed ID: 4405717
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the antineoplastic drug isophosphamide by rat liver microsomes.
    Allen LM; Creaven PJ
    J Pharm Pharmacol; 1972 Jul; 24(7):585-6. PubMed ID: 4403857
    [No Abstract]   [Full Text] [Related]  

  • 3. Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
    Alarcon RA; Meienhofer J; Atherton E
    Cancer Res; 1972 Nov; 32(11):2519-23. PubMed ID: 5082597
    [No Abstract]   [Full Text] [Related]  

  • 4. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.
    Connors TA; Cox PJ; Farmer PB; Foster AB; Jarman M
    Biochem Pharmacol; 1974 Jan; 23(1):115-29. PubMed ID: 4811053
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug metabolism by hepatic microsomes from phenobarbital-treated or starved male and female rats in the presence of inhibitors.
    Gigon PL; Bickel MH
    Life Sci II; 1971 Feb; 10(3):163-73. PubMed ID: 4252538
    [No Abstract]   [Full Text] [Related]  

  • 6. Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes.
    Alvares AP; Mannering GJ
    Mol Pharmacol; 1970 May; 6(3):206-12. PubMed ID: 5443528
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite.
    Hill DL; Laster WR; Kirk MC; el-Dareer S; Struck RF
    Cancer Res; 1973 May; 33(5):1016-22. PubMed ID: 4703116
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dietary protein quality on drug metabolism in the rat.
    Miranda CL; Webb RE
    J Nutr; 1973 Oct; 103(10):1425-30. PubMed ID: 4745519
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors involved in the inhibition of drug metabolism by (-)-emetine.
    Johnson RK; Mazel P; Donahue JD; Jondorf WR
    Biochem Pharmacol; 1971 May; 20(5):955-66. PubMed ID: 4400643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dealkylation of ethylmorphine and p-C-hydroxylation of aniline in liver microsomes of humans and male and female rats].
    Ackermann E
    Biochem Pharmacol; 1972 Aug; 21(16):2169-80. PubMed ID: 4646189
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of mechlorethamine and isophosphamide with bovine serum albumin and rat liver microsomes.
    Allen LM; Creaven PJ
    J Pharm Sci; 1973 May; 62(5):854-6. PubMed ID: 4705708
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidative drug metabolism in human liver microsomes.
    Nelson EB; Raj PP; Belfi KJ; Masters BS
    J Pharmacol Exp Ther; 1971 Sep; 178(3):580-8. PubMed ID: 4398379
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 15. Monooxygenase drug metabolizing activity in CaCl 2 -aggregated hepatic microsomes from rat liver.
    Kupfer D; Levin E
    Biochem Biophys Res Commun; 1972 May; 47(3):611-8. PubMed ID: 4402636
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols.
    Cohen GM; Mannering GJ
    Mol Pharmacol; 1973 May; 9(3):383-97. PubMed ID: 4145468
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the effects of halothane and CCl 4 on the hepatic drug metabolizing system.
    Davis DC; Schroeder DH; Gram TE; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):556-66. PubMed ID: 4398189
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of the mixed function oxidase system of rat hepatic microsomes to parathion and malathion and their oxygenated analogs.
    Stevens JT; Greene FE
    Life Sci; 1973 Dec; 13(12):1677-91. PubMed ID: 4149666
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.
    Cinti DL; Moldeus P; Schenkman JB
    Biochem Pharmacol; 1972 Dec; 21(24):3249-56. PubMed ID: 4405367
    [No Abstract]   [Full Text] [Related]  

  • 20. Microsomal electron transport reactions. II. The use of reduced triphosphopyridine nucleotide and-or reduced diphosphopyridine nucleotide for the oxidative N-demethylation of aminopyrine and other drug substrates.
    Cohen BS; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):46-53. PubMed ID: 4397837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.